Skip to content

Correlation between glymphatic dysfunction, accumulation of cerebrospinal fluid urea, and trigeminal neuralgia combined with depression

Correlation between glymphatic dysfunction, accumulation of cerebrospinal fluid urea, and trigeminal neuralgia combined with depression

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500110690
Enrollment
Unknown
Registered
2025-10-17
Start date
2025-11-01
Completion date
Unknown
Last updated
2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic pain combined with depression

Interventions

Trigeminal neuralgia combined with depression group:None
Trigeminal neuralgia without depression group:None
Healthy control group:None

Sponsors

Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed with classical trigeminal neuralgia according to the International Headache Society diagnostic criteria. 2. Age >= 18 years. 3. Provided written informed consent for the pre-operative assessment, intra-operative sampling, and post-operative follow-up. 4. No history of prior surgical interventions for trigeminal neuralgia, including percutaneous ganglion ablation (such as balloon Compression or radiofrequency thermocoagulation), stereotactic radiosurgery, or microvascular decompression etc..

Exclusion criteria

Exclusion criteria: 1. History of stroke, intracranial hemorrhage, brain tumor, severe traumatic brain injury, epilepsy, or neurodegenerative disorders (e.g., Alzheimer's disease, Parkinson's disease). 2. History of schizophrenia, bipolar disorder, or anxiety/depressive disorders that preceded the onset of trigeminal neuralgia. 3. Use of medications including sedative-hypnotics, diuretics, antidepressants, or glucocorticoids within the past 3 months. 4. Presence of severe systemic diseases (e.g., hepatic or renal insufficiency, advanced cancer). 5. Pregnancy or lactation. 6. Alcohol abuse. 7. History of substance abuse or dependence within the past 3 months. 8. Any contraindication to magnetic resonance imaging (MRI) or inability to complete the brain MRI scan due to excessive movement.

Design outcomes

Primary

MeasureTime frame
Diffusion tensor imaging along perivascular spaces Index;Cerebrospinal fluid urea concentration;Resting-State Functional MRI;

Secondary

MeasureTime frame
Enlarged Perivascular Space Score;Cerebrospinal fluid metabolites;Blood metabolites;Blood urea concentration;Hamilton Depression Rating Scale score;Pittsburgh Sleep Quality Index Scale score;Ascertain Dementia 8 Scale score;Brief Pain Inventory Scale score;Visual Analogue Scale score;

Countries

China

Contacts

Public ContactHuang Changsheng

Xiangya Hospital of Central South University

changsheng.huang@csu.edu.cn+86 159 7417 2150

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026